GENEVA and CONSTANȚA, Romania, April 24, 2026 (GLOBE NEWSWIRE) -- The Geneva College of Longevity Science (GCLS) today announced the launch of the world’s first PhD in Medicine with a specialization in Longevity Sciences, developed in academic partnership with Ovidius University of Constanța.
The four-year doctoral program represents a major milestone in the evolution of longevity science, designed to train a new generation of physician-scientists and researchers focused on preventive, healthspan-oriented healthcare and the clinical translation of aging biology.
“Longevity medicine has reached a point where the science is advancing faster than the institutions required to translate it responsibly into healthcare,” said Dominik Thor, President of GCLS. “With this PhD, we are building the academic and research infrastructure needed to support the field’s long-term development.”
From Emerging Science to Medical Discipline
Advances in aging biology, genomics, and digital health have created new opportunities to move beyond reactive care toward proactive risk management and healthspan preservation. Despite this progress, formal academic pathways in longevity science have remained limited.
The PhD in Longevity Sciences addresses this gap by providing structured doctoral training in:
- Biology of aging and longevity pathways
- Biomarkers and measurement of biological age
- Preventive, risk-stratified, and healthspan-oriented medicine
- Epidemiology of aging populations
- Ethical, regulatory, and health system considerations
The program reflects a broader shift in medicine - from treating disease after onset to addressing the underlying drivers of disease across the lifespan - and is grounded in evidence-based medicine.
By embedding longevity science within a formal doctoral framework, GCLS and Ovidius University aim to:
- Support the development of evidence-based longevity medicine
- Train researchers capable of translating science into clinical practice
- Contribute to sustainable, prevention-focused healthcare systems
- Establish academic standards in an emerging global field
Applications Now Open
The program is designed for graduates with a strong academic background and a research interest in aging biology, preventive medicine, or related fields.
More information and application details:
https://www.gcls.study/phd-programme
About Geneva College of Longevity Science (GCLS)
The Geneva College of Longevity Science (GCLS) is a Swiss-based higher education institute dedicated to longevity science, preventive medicine, and the clinical translation of aging biology into evidence-based healthcare practice.
Learn more: https://www.gcls.study
Press Contact
Geneva College of Longevity Science (GCLS)
Email: press@gcls.study
Website: https://gcls.ai -
意大利涂料协会主席突访瑞加总部,国内同行该紧张了近日,意大利涂料协会主席、同时也是蔻威玛(Covema)集团掌门人的Gianni Martinetti,现身意大利瑞加中国运营总部,引发高端涂装圈层关注。2026-04-24
-
EMZ鄂尔多斯联名苏州博物馆 开启东方美学着装新体验当快时尚的浪潮席卷全球,总有一些品牌选择在时光长河中逆流而上。EMZ鄂尔多斯男装以“长期主义”为舵,在文化联名的赛道上已深耕数载。自2023年3月官宣与苏州博2026-04-24
-
萤石发布EZVIZ AI CoreX:64T算力+Home Vita本地智能体,重新定义家庭AI中枢近日 ,萤石在2026年品牌新品发布会上重磅推出家庭智慧中枢——EZVIZ AI CoreX智能大模型主机。作为萤石“云-边-端”协同架构中的关键边侧核心,EZVIZ AI CoreX2026-04-24
-
爱尔英智唐琰:一台斜视手术,改写18岁少年的“灰暗”青春一次幼年高烧,几乎改变了小霖(化名)的整个青春。妈妈回忆,孩子小时候一次发烧后出现了斜视问题,右眼看东西会不自觉向外偏斜,与左眼不同。但只要小霖刻意控制,外观并不太2026-04-24
-
国网约68亿采购具身智能设备,机器人产业应用加速4月22日,国家电网有限公司内部印发《2026年具身智能发展规划》,计划在今年集中采购各类具身智能设备约8500台,总投资约68亿元,重点聚焦电力巡检、带电作业、应急救援2026-04-24
-
AMD股价暴跌17%创近9年之最,苏姿丰紧急回应:AI增速远超想象
-
江苏省脑机接口产业联盟在宁成立,麦澜德分享前沿成果
-
艾芬达入选国家知识产权强国建设示范创建对象:二十载长期主义,兑现每一份用户价值
-
慧启赣疆 聚势共赢丨慧友酒店集团江西品鉴会书写区域文旅融合新篇
-
电影《一秒》定档:2026年,活在这一秒
-
西藏斜视患儿寒假进京手术成功,千里护航点亮视觉未来
-
年度盛典|卓兴半导体2025年度总结表彰暨 2026 年迎新晚会
-
科技赋能 生态协同,登途集团车辆资产管理运营模式助推行业提质增效
-
公元地暖构建“产品+施工+服务”全维保障网,兑现50年温暖承诺
-
VCI Global 投资组合公司 Reveillon Group 与 NOWWA Coffee 达成战略合作,共同开拓马来西亚市场
